Emcure Pharmaceuticals will hold an earnings call on May 5, 2026, to discuss Q4 FY26 audited results.
The call will cover both standalone and consolidated financial performance for the quarter and year ended March 31, 2026.
A transcript and audio recording of the call will be made available on the company's website post-event.